Yifei Cheng

Donor‐derived<scp>CD</scp>19‐targeted T cell infusion induces minimal residual disease‐negative remission in relapsed B‐cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation

Yu‐Hong Chen, Yifei Cheng, Pan Suo et al. · British Journal of Haematology · 2017 · 102 citations · Full text

Cell Therapy, Immunology, Transplantation Medicine +20

Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation

Chen‐Hua Yan, Yu Wang, Xiao‐Dong Mo et al. · Clinical Infectious Diseases · 2018 · 67 citations · Full text

Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

Yu‐Hong Chen, Xian Zhang, Yifei Cheng et al. · Cytotherapy · 2020 · 42 citations

Cell Therapy, Transplantation, Marrow Transplantation +10

First‐line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy

Yifei Cheng, Zhengli Xu, Yuanyuan Zhang et al. · Clinical Transplantation · 2017 · 41 citations

Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era

Yu‐juan Xue, Yifei Cheng, Aidong Lu et al. · Biology of Blood and Marrow Transplantation · 2018 · 40 citations · Full text